Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Delaunois, Thierry*" or (type exact bookEditor and editor="Delaunois, Thierry*")

Add to list
- Conference Paper
- C3
Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC) : REGARD-C study

Alain Hendliz, Amélie Deleporte, Thierry Delaunois, Marc Peeters (UGent) , Gauthier Demolin, Jos Janssens, Stephane Holbrechts, Raphaël Maréchal, Javier Carasco, Marc Van Den Eynde, et al.

(2014) JOURNAL OF CLINICAL ONCOLOGY. 32(15, suppl.).
Add to list
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digstive Oncology

Ivan Borbath, Antonio Ceratti, Chris Verslype, Anne Demols, Thierry Delaunois, Stéphanie Laurent (UGent) , Anne Deleporte, Peter Vergauwe, A Van Maanen, Christine Sempoux, et al.

(2013) ANNALS OF ONCOLOGY. 24(11). p.2824-2829
Add to list
- Conference Paper
- C3
Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea

Alain Hendlisz, Marc Van Den Eynde, G Machiels, Isabel Dero, Karen Geboes (UGent) , Marc De Man, Koen Hendrickx, Thierry Delaunois, Els Monsaert, Eric Vanderstraeten, et al.

(2012) ACTA GASTRO-ENTEROLOGICA BELGICA. 75(1).
Add to list
- Conference Paper
- C3
- open access
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study

Ivan Borbath, Antonio Ceratti, Chris Verslype, Anne Demols, Thierry Delaunois, Stéphanie Laurent (UGent) , Amélie Deleporte, Philippe Vergauwe, Eric Van Cutsem and Jean-Luc Van Laethem

(2011) JOURNAL OF CLINICAL ONCOLOGY. 29(4, suppl.).

Academic Bibliography

Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC) : REGARD-C study

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digstive Oncology

Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study

Contents

Support

Contact